Filing Flows › Century Therapeutics (IPSC) › Next earnings date
Century Therapeutics (IPSC) earnings on Nov 12, 2026: what to expect
Century Therapeutics (IPSC) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.11 (−$0.12 to −$0.08, 4 estimates), against −$0.32 a year ago. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 84% chance of beating next time.
What to watch
Last quarter (Q1 2025) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.32, against the analysts' −$0.11.
The last report
Century Therapeutics reported revenue of $109M for the first quarter 2025 (128× Y/Y), net earnings $76.6M. How it makes money → · Every quarter →
Century Therapeutics' latest quarter
Century Therapeutics, Q1 2025: revenue $109M (128× year over year), operating margin 67.9%, net earnings $76.6M, operating cash flow −$34.6M. The chart follows the revenue to costs, profit and cash.
Questions
When does IPSC report earnings?
Century Therapeutics is expected to report on Nov 12, 2026 (estimated).
What are analysts expecting from Century Therapeutics?
EPS of −$0.11 for the quarter.
Does Century Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 100% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.